Why this matters for fleets and owner-operators

The Treasury Department and IRS said on April 23, 2026, that they will issue tax guidance in response to the Justice Department’s new Final Order moving FDA‑approved marijuana products and state‑licensed medical cannabis into Schedule III. Because Section 280E only bars deductions for Schedule I or II trafficking, Treasury signaled that qualifying medical cannabis businesses will regain access to ordinary deductions and credits, with transition and apportionment rules coming for mixed operations. For carriers serving licensed medical operators—or fleets with cannabis-adjacent subsidiaries—this is a near-term shift with balance‑sheet implications.

What changed—and when

DOJ’s Final Order took effect April 22, 2026, immediately reclassifying two categories: FDA‑approved marijuana drug products and marijuana “subject to a qualifying state‑issued medical marijuana license,” while leaving unlicensed cannabis and adult‑use markets in Schedule I. That status change is what unlocks relief from 280E for qualifying medical operators; adult‑use businesses remain under 280E.

What the forthcoming IRS guidance is expected to cover

Treasury previewed three key pieces: (1) confirmation that 280E no longer applies to activities that, because of the Final Order, are not Schedule I or II; (2) rules for apportioning expenses in businesses with multiple activities so that 280E applies only to Schedule I/II lines; and (3) a transition rule treating rescheduling as effective for the taxpayer’s full taxable year that includes April 22, 2026. Practically, that means medical lines can plan to deduct ordinary and necessary expenses this tax year, while keeping clean books that separate any adult‑use operations that still trigger 280E.

Implications for trucking and logistics

Freight mix and lanes: Law‑firm analyses note the Order opens a pathway for transactions—and transport—between DEA‑registered facilities in interstate commerce. That could expand compliant medical‑cannabis freight opportunities for specialized carriers and 3PLs working with registered shippers/consignees. Expect heightened documentation and chain‑of‑custody expectations from customers.
Security and loss reporting: DEA rules place responsibility on registrant shippers to select common or contract carriers that provide “adequate security” and to report in‑transit losses promptly. Carriers hauling Schedule III product should be ready to demonstrate security protocols and incident reporting discipline.
Warehousing: If you operate freight‑forwarding or cross‑dock facilities as a registrant (or on behalf of one), DEA security controls apply, including controlled‑access storage and monitored alarm coverage.
Driver workforce: DOT’s stance has not changed—safety‑sensitive employees cannot use marijuana. A positive THC test remains a violation with Clearinghouse consequences, regardless of state medical status or federal rescheduling of certain products. Keep policies and education current.

Financial takeaways for carriers serving the sector

For fleets tied to vertically integrated medical operators—or for private fleets inside MSOs—the removal of 280E on medical lines could lower effective tax rates materially, freeing cash for rate stability, equipment refreshes, or contract capacity. Pre‑Order, some operators faced effective tax rates approaching 75% because ordinary deductions were disallowed; post‑Order, deductible OPEX should improve margins for medical programs. But adult‑use operations still face 280E, so shippers with both lines will likely segregate expenses and renegotiate contracts to reflect deductible vs. non‑deductible cost centers.

Action steps before peak shipping season

Ask your medical‑cannabis customers about DEA registration status and any updated SOPs for Schedule III shipments; align your carrier security attestations accordingly.
Segment your customer portfolio: medical vs. adult‑use. Expect different cost expectations as 280E relief flows to medical but not adult‑use businesses.
Update contracts to reflect custody, loss‑reporting timelines, and documentation requirements tied to controlled‑substance freight.
Re‑train dispatch and safety on unchanged DOT drug‑testing rules and reinforce driver education on THC risks.
For fleets within cannabis businesses: prepare to apportion expenses so medical lines capture deductions once IRS guidance lands; coordinate with tax counsel on transition timing for the 2026 taxable year.

Bottom line: The DOJ’s April 22 Order moved state‑licensed medical cannabis into Schedule III, and Treasury’s April 23 announcement means IRS guidance is on the way. Medical operators—and the carriers that serve them—should prepare for 280E relief on medical lines, tighter DEA‑aligned transport protocols, and unchanged DOT drug‑testing obligations. Adult‑use operations are unchanged for now, with broader rescheduling headed to an expedited hearing starting June 29, 2026.

Editor’s note: This article focuses on federal changes. State laws on licensing, transport, and product handling still apply in every lane you run.

Sources Consulted: U.S. Department of the Treasury; U.S. Department of Justice; Foley Hoag LLP; Foley & Lardner LLP; MarijuanaPhysician.com.

Need to file your Form 2290?

Join thousands of owner-operators and carriers who trust HeavyTax.com for fast and easy HVUT e-filing.

This article was prepared exclusively for truckstopinsider.com. For professional tax advice, consult a qualified professional.